carbapenems has been researched along with Bacteroides Infections in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burián, K; Hajdú, E; Matuz, M; Sóki, J; Wirth, R; Wybo, I | 1 |
| Baghi, HB; Bazmani, A; Beheshtirouy, S; Farzinazar, A; Memar, MY; Rezaee, MA; Sóki, J; Yekani, M | 1 |
| Gao, X; Guo, B; Wang, J; Wang, Y; Wang, Z; Wen, J | 1 |
| Gao, Q; Hu, F; Huang, H; Wu, S; Xu, T; Zhao, X | 1 |
| Cunningham, SA; Jeraldo, PR; Khare, R; Patel, R; Sadarangani, SP; Wilson, JW | 1 |
| Goldstein, EJ; Harrell, L; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Newton, D; Patel, R; Snydman, DR | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
| Hackel, M; Hawser, SP; Hoban, DJ | 1 |
| Chong, Y; Jeong, SH; Kim, CK; Kim, JM; Kim, MS; Kim, S; Lee, K; Roh, KH; Yong, D; Yum, JH | 1 |
| Balkan, N; Ilki, A; Ozel, N; Söyletir, G; Toprak Ülger, N | 1 |
| Sóki, J; Soyletir, G; Toprak, NU; Uzunkaya, OD | 1 |
| Bianchini, H; Carloni, G; Castello, L; Cejas, D; Di Martino, A; Fernández-Canigia, L; Gutkind, G; Legaria, MC; Litterio, M; Predari, SC; Radice, M; Rollet, R; Rossetti, A | 1 |
| Eitel, Z; Nagy, E; Sóki, J; Urbán, E | 1 |
| Goldstein, EJ | 1 |
| Beer, Z; Edwards, R; Fodor, E; Nagy, E; Sóki, J; Urbán, E | 1 |
| Edwards, R; Fang, H; Hedberg, M; Nagy, E; Nord, CE; Sóki, J | 1 |
| Andrews, J; Ang, L; Brenwald, NP; Fraise, A; Walker, RM | 1 |
| Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T | 1 |
| Aldridge, KE; Karam, GH; Sanders, CV | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
2 review(s) available for carbapenems and Bacteroides Infections
| Article | Year |
|---|---|
Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests | 2022 |
Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bacteroides Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Streptococcal Infections | 1991 |
18 other study(ies) available for carbapenems and Bacteroides Infections
| Article | Year |
|---|---|
A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Belgium; Carbapenems; Drug Resistance, Bacterial; Feces; Gastrointestinal Microbiome; Humans; Hungary; Microbial Sensitivity Tests | 2022 |
High prevalence of cfiA positive Bacteroides fragilis isolates collected at a teaching hospital in Hohhot, China.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Child; China; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Prevalence | 2023 |
Emergence of carbapenem resistance in Bacteroides fragilis in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing | 2019 |
Metronidazole- and carbapenem-resistant bacteroides thetaiotaomicron isolated in Rochester, Minnesota, in 2014.
Topics: Abscess; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides; Bacteroides Infections; beta-Lactamases; Carbapenems; Diverticulitis, Colonic; DNA, Bacterial; Drug Resistance, Bacterial; Empyema; Genome, Bacterial; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Minnesota; Surgical Wound Infection | 2015 |
Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
Topics: Anti-Infective Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Bacteroidetes; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States | 2017 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Carbapenems; Europe; Humans; Microbial Sensitivity Tests | 2010 |
New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Humans; Molecular Sequence Data; Republic of Korea; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2010 |
[Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Feces; Humans; Imipenem; Meropenem; Metalloproteins; Microbial Sensitivity Tests; Thienamycins; Turkey | 2011 |
Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Turkey | 2012 |
First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Bacteroides; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactamases; Body Fluids; Carbapenems; Cross-Sectional Studies; Edetic Acid; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Population Surveillance | 2012 |
Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides; Bacteroides Infections; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Europe; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2013 |
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Screening of isolates from faeces for carbapenem-resistant Bacteroides strains; existence of strains with novel types of resistance mechanisms.
Topics: Bacterial Proteins; Bacteroides; Bacteroides Infections; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Feces; Humans | 2004 |
Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; Base Sequence; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Population Surveillance; Thienamycins | 2006 |
Carbapenem resistance in Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests | 2007 |
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases | 2000 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |